Quent Capital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Quent Capital's CRL Position: Q3 2026 in Review
Quent Capital increased its Charles River Laboratories (CRL) stake by 25% in Q3 2026, buying an estimated $8.43K and bringing the position to 159 shares worth $46.9K. The position accounts for ﹤0.01% of the portfolio, ranked #842.
Quent Capital first reported a position in CRL in Q4 2021 and has held it in 19 quarters since. The position peaked at $48.8K in Q1 2024. 646 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Quent Capital held 159 shares of Charles River Laboratories worth $46.9K as of Q3 2026.
- Quent Capital bought 32 Charles River Laboratories shares in Q3 2026, an estimated $8.43K.
- Charles River Laboratories made up ﹤0.01% of Quent Capital's portfolio in Q3 2026, its #842 holding.
- Quent Capital first reported a position in Charles River Laboratories in Q4 2021 and has held it in 19 quarters since.
- Quent Capital's Charles River Laboratories position peaked at $48.8K in Q1 2024.
- 646 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.